HealthEquity Reports Fourth Quarter and Fiscal Year Ended January 31, 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
HealthEquity, Inc (HQY) PT Raised to $98 at Oppenheimer
March 19, 2019 9:30 AM EDTOppenheimer analyst Mohan Naidu raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $98.00 (from $74.00) while maintaining a Outperform rating.
The analyst commented, "HQY wrapped up the year at the higher end of the pre-released FY19 numbers at revenue/adj. EPS of... More
HealthEquity (HQY) Tops Q4 EPS by 5c, FY EPS Guidance Misses
March 18, 2019 4:08 PM EDTHealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.27, $0.05 better than the analyst estimate of $0.22. Revenue for the quarter came in at $75.8 million versus the consensus estimate of $74.09 million.
GUIDANCE:
HealthEquity sees FY2020 EPS of $1.23-$1.29, versus the consensus of $1.31. HealthEquity sees... More
